Clinical trials
Hyperglycemia trials in China with no applicable phase
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
11 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2014 | 1 |
| 2016 | 1 |
| 2019 | 1 |
| 2020 | 3 |
| 2021 | 1 |
| 2022 | 2 |
| 2023 | 1 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 6 |
| Unknown status | 4 |
| Recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Huazhong University of Science and Technology | 2 |
| Sun Yat-sen University | 2 |
| Westlake University | 2 |
| China National Center for Cardiovascular Diseases | 1 |
| First Affiliated Hospital Xi'an Jiaotong University | 1 |
| Kang Yan | 1 |
| Shenzhen Precision Health Food Technology Co. Ltd., | 1 |
| Zhejiang University | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hyperglycemia | 11 |
| Diabetes Mellitus | 4 |
| Diabetes Mellitus, Type 2 | 2 |
| Glucose Metabolism Disorders | 2 |
| Hyperlipidemias | 2 |
| Insulin Resistance | 2 |
| Obesity | 2 |
| Critical Illness | 1 |
| Glucose Intolerance | 1 |
| Hyperinsulinism | 1 |
Trials
Showing 1 to 11 of 11. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.